HS6ST2 ELISA Kit

Produktnummer ABIN2043629

Produktdetails HS6ST2 ELISA Kit

Target: HS6ST2 (Heparan Sulfate 6-O-Sulfotransferase 2 (HS6ST2))

Reaktivität: Human

Nachweismethode: Colorimetric

Methodentyp: Sandwich ELISA

Detektionsbereich: 0.15-10 ng/mL

Untere Nachweisgrenze: 0.15 ng/mL

Applikation: ELISA

Marke: BioAssay™

Sensitivität: < 0.053 ng/mL

Anwendungsinformationen

Plattentyp: Pre-coated

Protokoll: Heparan Sulfate-6-O-Sulfotransferase 2 (HS6ST2) BioAssay-ELISA Kit (Human) is a Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Heparan Sulfate-6-O-Sulfotransferase 2 (HS6ST2). Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody specific to Heparan Sulfate-6-O-Sulfotransferase 2 (HS6ST2). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Heparan Sulfate-6-O-Sulfotransferase 2 (HS6ST2), biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm±10nm. The concentration of Heparan Sulfate-6-O-Sulfotransferase 2 (HS6ST2) in the samples is then determined by comparing the O.D. of the samples to the standard curve.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Lagerung: 4 °C/-20 °C

Details zu HS6ST2

Target: HS6ST2 (Heparan Sulfate 6-O-Sulfotransferase 2 (HS6ST2))

Andere Bezeichnung: Heparan Sulfate-6-O-Sulfotransferase 2 (HS6ST2) (HS6ST2 Produkte)

Synonyme: 6OST2 ELISA Kit, RGD1563872 ELISA Kit, RGD1564397 ELISA Kit, HS6ST-2 ELISA Kit, fb80f12 ELISA Kit, hs6st ELISA Kit, wu:fb80f12 ELISA Kit, heparan sulfate 6-O-sulfotransferase 2 ELISA Kit, HS6ST2 ELISA Kit, Hs6st2 ELISA Kit, hs6st2 ELISA Kit

Pathways: Glycosaminoglycan Metabolic Process, SARS-CoV-2 Protein Interaktom